20.02.2024
Acino appoints Ingrid Eberle as Chief Compliance and Sustainability Officer
We are proud to announce the appointment of Ingrid Eberle as Chief Compliance and Sustainability Officer, effective 1 March 2023....
We are proud to announce the appointment of Ingrid Eberle as Chief Compliance and Sustainability Officer, effective 1 March 2023....
The agreement focuses on the distribution of orphan drugs developed for patients with conditions such as rheumatoid arthritis, cryopyrin-associated periodic...
For the third consecutive year, Acino South Africa has been awarded with the Top Employer certification. The Top Employer certification is one...
With nearly 300 new employees on board, Acino will enhance its presence in Latin America and strengthen its business through...
Antimicrobial resistance (AMR) is a global health concern that threatens the effectiveness of antibiotics and other antimicrobial medicines. It has the...
In line with Acino’s commitment to improving patients’ lives, we regularly organise health awareness initiatives with our employees, the ambassadors...
Acino, recognizes the significance of cardiovascular health and is dedicated to advancing heart care through innovative solutions and patient education....
Dedication and expertise are key qualities needed to deliver flexible solutions. We are fortunate to have a group of experts...
Over 300 M8 employees, product portfolio and pipeline to enhance Acino’s footprint and strategic position in key Latin American markets....